Acetylcholinesterase inhibitory activity of phlorotannins isolated from the brown alga, Ecklonia maxima (Osbeck) Papenfuss

Food Research International

Volumn 54, Issue 1, 2013, Pages 1250-1254

  Kannan, Rengasamy R R ^a   Aderogba, Mutalib A ^a   Ndhlala, Ashwell R ^a   Stirk, Wendy A ^a   Van Staden, Johannes ^a  

^a UNIVERSITY OF KWAZULU NATAL   (South Africa)

Author keywords

Acetylcholinesterase; Ecklonia maxima; Neurodegenerative disorders; Phloroglucinol derivatives

Indexed keywords

1 ,3 ,5-TRIHYDROXYBENZENE; ACETYLCHOLINESTERASE; ECKLONIA MAXIMA; NEURODEGENERATIVE DISORDERS; NUTRITIONAL SUPPLEMENTS; PHLOROGLUCINOL DERIVATIVES; SPECTROSCOPIC TECHNIQUE; STRUCTURE ELUCIDATION;

ION EXCHANGE; MASS SPECTROMETRY; NEURODEGENERATIVE DISEASES; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY;

GALLIUM ALLOYS;

ANIMALIA; ECKLONIA; ECKLONIA MAXIMA; PHAEOPHYCEAE;

EID: 84885684873     PISSN: 09639969     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.foodres.2012.11.017     Document Type: Article

References (35)

1. Alzheimer's Association Alzheimer's disease facts and figures. Alzheimer's & Dementia 2012, 8:131-168.
2. Anderson R.J., Bolton J.J., Molloy F.J., Rotmann K.W.G. Commercial seaweed production and research in southern Africa. Proceedings of the 17th International Seaweed Symposium 2003, 1-12. Oxford University Press, Oxford. A.R.O. Chapman, R.J. Anderson, V.J. Vreeland, I.R. Davison (Eds.).
3. Anderson R.J., Rand A., Rothman M.D., Bolton J.J. Mapping and quantifying the South African kelp resource. African Journal of Marine Science 2007, 29:369-378.
4. Apostolidis E., Lee C.M. Brown seaweed-derived phenolic phytochemicals and their biological activities for functional food ingredients with focus on Ascophyllum nodosum. Handbook of marine macroalgae: Biotechnology and applied phycology 2012, 356-370. John Wiley & Sons, Ltd, West Sussex, UK. S.K. Kim (Ed.).
5. Artan M., Li Y., Karadeniz F., Lee S.H., Kim M.M., Kim S.K. Anti-HIV-1 activity of phloroglucinol derivative, 6,60-bieckol, from Ecklonia cava. Bioorganic & Medicinal Chemistry 2008, 16:7921-7926.
6. Ellman G.L., Coutney D., Andies V., Featherstone R.M. A new and rapid colourimetric determination of acetylcholinesterase activity. Biochemical Pharmacology 1961, 7:88-95.
7. Food and Agriculture Organization of the United Nations (FAO) The State of World Fisheries and Aquaculture SOFIA 2012 2012, 40-41. FAO Fisheries Department, Rome.
8. Jorm A.F., Jolley D. The incidence of dementia: A meta-analysis. Neurology 1998, 51:728-733.
9. Jung H.A., Hyun S.K., Kim H.R., Choi J.S. Angiotensin converting enzyme I inhibitory activity of phlorotannins from Ecklonia stolonifera. Fisheries Science 2006, 72:1292-1299.
10. Kim S.K., Himaya S.W.A. Medicinal effects of phlorotannins from marine brown algae. Marine medicinal foods: Implications and applications, macro and microalgae 2011, 97-109. Elsevier Inc., USA. S.K. Kim (Ed.).
11. Kim A.R., Shin T.S., Lee M.S., Park J.Y., Park K.E., Yoon N.Y., et al. Isolation and identification of phlorotannins from Ecklonia stolonifera with antioxidant and anti-inflammatory properties. Journal of Agricultural and Food Chemistry 2009, 57:3483-3489.
12. Kong C.S., Kim J.A., Yoon N.Y., Kim S.K. Induction of apoptosis by phloroglucinmol derivative from Ecklonia cava in MCF-7 human breast cancer cells. Food and Chemical Toxicology 2009, 47:1653-1658.
13. Li Y., Qian Z.J., Ryu B.M., Lee S.H., Kim M.M., Kim S.K. Chemical components and its antioxidant properties in vitro: an edible marine brown alga, Ecklonia cava. Bioorganic & Medicinal Chemistry 2009, 17:1963-1973.
14. Li J., Wei Y., Du G., Hu Y., Li L. Anticoagulant activities of phlorotannins from Sargassum thunbergii. Zhongyao Xinyao Yu Linchuang Yaoli 2007, 18:191-194.
15. Liu L., Heinrich M., Myers S., Dworjanyn S.A. Towards better understanding of medicinal uses of the brown seaweed Sargassum in Traditional Chinese medicine: A phytochemical and pharmacological review. Journal of Ethnopharmacology 2012, 142:591-619.
16. Lopes G., Sousa C., Silva L.R., Pinto E., Andrade P.B., Bernardo J., et al. Can phlorotannins purified extracts constitute a novel pharmacological alternative for microbial infections with associated inflammatory conditions?. PLoS One 2012, 7. 10.1371/journal.pone.0031145.
17. Mayer A.M.S., Rodríguez A.D., Berlinck R.G.S., Fusetani N. Marine pharmacology in 2007-8: Marine compounds with antibacterial, anticoagulant, antifungal, anti-inflammatory, antimalarial, antiprotozoal, antituberculosis, and antiviral activities; affecting the immune and nervous system, and other miscellaneous mechanisms of action. Comparative Biochemistry and Physiology Part C: Toxicology & Pharmacology 2011, 153:191-222.
18. Melzer D. New drug treatment for Alzheimer's disease: Lessons for healthcare policy. British Medical Journal 1998, 316:762-764.
19. Mishra S., Palanivelu K. The effect of curcumin (turmeric) on Alzheimer's disease: An overview. Annals of Indian Academy of Neurology 2008, 11:13-19.
20. Moon C., Kim S.H., Kim J.C., Hyun J.W., Lee N.H., Park J.W., et al. Protective effect of phlorotannin components phloroglucinol and eckol on radiation-induced intestinal injury in mice. Phytotherapy Research 2008, 22:238-242.
21. Moyo M., Ndhlala A.R., Finnie J.F., Van Staden J. Phenolic composition, antioxidant and acetylcholinesterase inhibitory activities of Schlerocarya birrea and Harpephyllum caffrum (Anacardiaceae) extracts. Food Chemistry 2010, 123:69-76.
22. Nagayama K., Iwamura Y., Shibata T., Hirayama I., Nakamura T. Bactericidal activity of phlorotannins from the brown alga Ecklonia kurome. Journal of Antimicrobial Chemotherapy 2002, 50:889-893.
23. Nwosu F., Morris J., Lund V.A., Stewart D., Ross H.A., McDougall G.J. Anti-proliferative and potential anti-diabetic effects of phenolic rich extracts from edible marine algae. Food Chemistry 2011, 126:1006-1012.
24. Okada Y., Ishimaru A., Suzuki R., Okuyama T. A new phloroglucinol derivative from the brown alga Eisenia bicyclis: potential for the effective treatment of diabetic complications. Journal of Natural Products 2004, 67:103-105.
25. Orhan I., Sener B., Choudhary M.I., Khalid A. Acetylcholinesterase and butyrylcholinesterase inhibitory activity of some Turkish medicinal plants. Journal of Ethnopharmacology 2004, 91:57-60.
26. Pangestuti R., Kim S.K. Neuroprotective effects of marine algae. Marine Drugs 2011, 9:803-818.
27. Parys S., Kehraus S., Krick A., Glombitza K.W., Carmeli S., Klimo K., et al. In vitro chemopreventive potential of fucophlorethols from the brown alga Fucus vesiculosus L. by anti-oxidant activity and inhibition of selected cytochrome P450 enzymes. Phytochemistry 2010, 71:221-229.
28. Ragan M.A., Glombitza K.W. Phlorotannins, brown algal polyphenols. Progress in Phycological Research 1986, 4:129-241.
29. Risa A., Risa J., Adsersen A., Stafford G.I., Van Staden J., Jäger A.K. Acetylcholinesterase inhibitory activity of plants used as memory-enhancers in traditional South African medicine. South African Journal of Botany 2004, 70:664-666.
30. Schulz V. Ginkgo extract or cholinesterase inhibitors in patients with dementia: What clinical trials and guidelines fail to consider. Phytomedicine 2003, 10:74-79.
31. Small G.W., Rabins P.V., Barry P.P., Buckholts N.S., Dekosky S.T., Ferris S.H., et al. Diagnosis and treatment of Alzheimer disease and related disorders. Journal of the American Medical Association 1997, 278:1363-1371.
32. Wei Y., Wang C., Li J., Guo H. Effects of high-molecular-weight phlorotannins from Sargassum thunbergii Kuntze on anticoagulant activity and platelet cytosolic calcium level. Zhongguo Yaoke Daxue Xuebao 2008, 39:257-261.
33. Yoon N.Y., Chung H.Y., Kim H.R., Choi J.S. Aectyl-and butrylcholinesterase inhibitory activities of sterols and phlorotannins from Ecklonia stolonifera. Fisheries Science 2008, 74:200-207.
34. Yoon N.Y., Lee S.H., Li Y., Kim S.K. Phlorotannins from Ishige okamurae and their acetyl- and butyrylcholinesterase inhibitory effects. Journal of Functional Foods 2009, 1:331-335.
35. Zhang R., Kang K.A., Piao M.J., Ko D.O., Wang Z.H., Lee I.K., et al. Eckol protects V79-4 lung fibroblast cells against ray radiation-induced apoptosis via the scavenging of reactive oxygen species and inhibiting of the c-Jun NH2-terminal kinase pathway. European Journal of Pharmacology 2008, 591:114-123.